Sept 10, 2009 KEI brownbag lunch on Bilski litigation

KEI will host a meeting on the Bilski litigation regarding patents on business methods, on September 10, 2009, from noon to 2:00.
When: Thursday, September 10, 2009
Time: 12:00-2:00pm

Knowledge Ecology International (KEI)
1621 Connecticut Ave NW, Suite 500
Washington, DC 20009
Tel +1 202 332 2670

The meeting will include presentations by:

Syngenta AG on patent pools and prizes

On July 14, 2009, at the WIPO Conference on Intellectual Property and Public Policy Issues, Michael Kock (Global Head IP Seeds and Biotechnology at Syngenta International AG) underscored that today’s global challenges can only dealt with in an efficient manner by creating innovation networks which included the reward of substantial amounts of money to solve technical challenges and problems.

President Obama picks David Kappos as USPTO Director, first open source fan to run USPTO

Our impressions about this appointment are positive, but we would like to hear from others. IBM has been very smart on IPR issues lately, recognizing that knowledge is often more valuable when shared. Coming from a successful technology firm, he will have both credibility and insight into innovation policy. He brings more balance to the job than anyone we can remember. Below are some interesting quotes from various articles.

India, Indonesia, Philippines, Sri Lanka, South Africa, Egypt: Consolidated proposals for Chair’s Summary

May 8, 2009

The following text was submitted by the Like-Minded Group (India, Indonesia, Philippines, Sri Lanka, South Africa, Egypt) on Friday, 8 May 2009, for consideration by the PCT Working Group. It is a best endeavor to consolidate the four proposals made yesterday by the African Group, Group B, GRULAC and the aforementioned like-minded Group.


Proposal of Group B for Recommendation to the PCT Assembly

Proposal of Group B for Recommendation to the Assembly

The Working Group of the PCT recognizes the willingness of all Contracting Parties to commit to developing the PCT in order to meet the needs of all applicants, Offices, third parties and the general public. Following its discussion of the roadmap presented in the document PCT/WG/2/3, the PCT Working Group makes the following recommendations to the Assembly.

India, Indonesia, Philippines, Sri Lanka, South Africa, Egypt: Inputs for chair’s summary proposed

India, Indonesia, Philippines, Sri Lanka, South Africa and Egypt have just provided inputs for the Chair’s (Canada, Alan Troicuk, Senior Counsel, Canadian Intellectual Property Office), Summary of the Working Group of the Patent Cooperation Treaty (PCT). The Philippines made the intervention on behalf of the group of like minded countries.

Inputs for chair’s summary proposed by group of like minded countries

GRULAC recommendations to Working Group to the PCT Assembly

Today is day four of the second session of the International Patent Cooperation Union (PCT) Working Group of the Patent Cooperation Treaty (PCT) taking place at WIPO. Here below are the suggestions of the Group of Latin American and Caribbean Member States (GRULAC) would like to be incorporated into the recommendation of the Working Group to the PCT Assembly.The Members of GRULAC that are contracting-parties to the PCT Treaty suggest the addition of the following elements into the recommendation of the Working Group to the PCT Assembly.

EC’s two medicines in transit exceptions

At the WIPO SCP coffee break, one attendee explained to KEI that the EU has in two places, (1) the regulations on tiered pricing, and (2) the implementation of the WTO’s 30 August 2003 decision on compulsory licensing, created an exception for goods in transit to developing countries.

DG Trade and DG Customs Union reply to TACD on Seizures of Medicines in Transit

The European Commissioners for External Trade and for Taxation and Customs Union have replied to TACD in a letter available here:

Dear All,

KEI reaction to GSK announcement on patent pool for neglected diseases

As an early proponent of the use of patent pools to expand access to medical technologies, our initial reaction to the GSK announcement is that GSK is responding to several new developments.

Syndicate content